Vital Signs - Prefilled Syringes: Injecting the End-Users Perspective
Vital Signs - Prefilled Syringes: Injecting the End-Users Perspective
RELEASE DATE
17-May-2010
17-May-2010
REGION
North America
North America
Research Code: 9561-00-A7-00-00
SKU: HC00596-NA-MR_04069
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00596-NA-MR_04069
Description
This issue of Vital Signs, released on May 17, 2010, provides a strategic overview of key issues and trends relating to prefilled syringes in drug delviery. Additionally, a company spotlight is provided for Vanda Pharmaceuticals, a biopharmaceutical company utilizing novel technologies, including genetics and genomics, to discover, develop and commercialize drug candidates for central nervous system (CNS) disorders. Reimbursement and regulatory news from the FDA is also provided for the week of April 26, 2010.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on May 17, 2010, provides a strategic overview of key issues and trends relating to prefilled syringes in drug delviery. Additionally, a company spotlight is provided for Vanda Pharmaceuticals, a biopharmaceutical company utilizing novel technologies, including genetics and genomics, to discover, develop and commercialize drug candidates for central nervous system (CNS) disorders. Reimbursement and regulatory news from the FDA is also provided for the week of April 26, 2010.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-A7-00-00 |
Is Prebook | No |